Lemaitre Vascular (LMAT) Short-term Investments (2017 - 2026)

Lemaitre Vascular (LMAT) has 10 years of Short-term Investments data on file, last reported at $340.4 million in Q1 2026.

• Quarterly Short-term Investments rose 22.79% year-over-year to $340.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $340.4 million (up 22.79% YoY) and the FY2025 annual result came in at $330.9 million, up 20.71% from the prior year.
• Short-term Investments improved to $340.4 million in Q1 2026 per LMAT's latest filing, from $330.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $340.4 million in Q1 2026 and bottomed at $54.9 million in Q2 2022.
• The 5-year median for Short-term Investments is $81.7 million (2024), against an average of $155.3 million.
• Peak annual rise in Short-term Investments reached 25751.4% in 2022, while the deepest fall reached 13.28% in 2022.
• Tracing LMAT's Short-term Investments over 5 years: stood at $63.6 million in 2022, then increased by 27.14% to $80.8 million in 2023, then soared by 239.23% to $274.1 million in 2024, then grew by 20.71% to $330.9 million in 2025, then increased by 2.87% to $340.4 million in 2026.
• Per Business Quant, the three latest LMAT Short-term Investments figures stand at $340.4 million (Q1 2026), $330.9 million (Q4 2025), and $317.6 million (Q3 2025).

Peer Comparison